Document is current
Any future updates will be listed below
-
Authors
Strouphauer, Emily R. https://orcid.org/0000-0002-3967-8500
Morris, Olivia J. https://orcid.org/0000-0003-2721-989X
Soileau, Keaton J. https://orcid.org/0000-0002-5564-3738
Wiese, Andrew D. https://orcid.org/0000-0002-5181-0674
Quast, Troy https://orcid.org/0000-0001-8564-3379
Goodman, Wayne K. https://orcid.org/0000-0001-6717-082X
Sheth, Sameer A. https://orcid.org/0000-0001-8770-8965
Wojcik, Katharine D. https://orcid.org/0000-0003-4964-4248
Guzick, Andrew G. https://orcid.org/0000-0002-4159-9203
Storch, Eric A. https://orcid.org/0000-0002-7631-3703
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103555)
National Institute of Neurological Disorders and Stroke (1UH3NS100549)
- License Information
-
More Information
Article History
Accepted: 6 February 2023
First Online: 25 February 2023
Declarations
:
: Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number P50HD103555 for use of the Clinical and Translational Core facilities, as well as by the National Institutes of Health BRAIN Initiative under Award Number 1UH3NS100549. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
: Emily R. Strouphauer, Olivia J. Morris, Keaton J. Soileau, Andrew D. Wiese, Troy Quast, and Katharine D. Wojcik have no disclosures to report. Wayne K. Goodman reports receiving research funding from the National Institutes of Health, Biohaven, and the McNair Foundation and consulting fees from Biohaven. Sameer A. Sheth discloses the following relationships: he is a consultant for Boston Scientific, Zimmer Biomet, Koh Young, and Neuropace. He is the co-founder of Motif Neurotech. Andrew G. Guzick discloses the following relationships: grant support from the Texas Higher Education Coordinating Board. Eric A. Storch reports receiving research funding to his institution from the Ream Foundation, International OCD Foundation, and the National Institutes of Health. He is a consultant for Brainsway and Biohaven Pharmaceuticals. He owns stock less than $5000 in NView. He receives book royalties from Elsevier, Wiley, Oxford, American Psychological Association, Guildford, Springer, and Jessica Kingsley.
: Not applicable.
: Not applicable.
: Not applicable.
: The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.
: Not applicable.
: The authors confirm contribution to the article as follows: study conception and design: ERS, EAS, KDW; data collection: ERS, OJM, KJS; analysis and interpretation of results: ERS, TQ, ADW, AGG, EAS; draft manuscript preparation: ERS, ADW, TQ, WKG, SAS, AGG, EAS. All authors reviewed the results and approved the final version of the manuscript.
